EUPATI - the European Patients' Academy on Therapeutic Innovation, has just published its newsletter for the second quarter of 2013.
The European project aims to provide scientifically reliable, objective, comprehensive information to patients on pharmaceutical R&D. It will increase the capacity of well-informed patients to be effective advocates and advisors, for example in clinical trials, with regulatory authorities and in ethics committees. A consortium of 29 organisations, led by the European Patients' Forum, comprises a unique combination of pan-European patient organisations, academic and not-for profit organisations expert in patient and public engagement and EFPIA member companies. It features excellence in state-of-the art, high quality, objective education to patients about therapeutic innovation.
To read the newsletter, click here.